Siga Technologies (SIGA) Competitors $6.74 +0.06 (+0.82%) Closing price 07/3/2025 03:40 PM EasternExtended Trading$6.74 0.00 (0.00%) As of 07/3/2025 04:50 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsDividendEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock SIGA vs. TARS, BEAM, CNTA, ARQT, ADPT, IMCR, SPRY, EWTX, SDGR, and BHVNShould you be buying Siga Technologies stock or one of its competitors? The main competitors of Siga Technologies include Tarsus Pharmaceuticals (TARS), Beam Therapeutics (BEAM), Centessa Pharmaceuticals (CNTA), Arcutis Biotherapeutics (ARQT), Adaptive Biotechnologies (ADPT), Immunocore (IMCR), ARS Pharmaceuticals (SPRY), Edgewise Therapeutics (EWTX), Schrodinger (SDGR), and Biohaven (BHVN). These companies are all part of the "pharmaceutical products" industry. Siga Technologies vs. Its Competitors Tarsus Pharmaceuticals Beam Therapeutics Centessa Pharmaceuticals Arcutis Biotherapeutics Adaptive Biotechnologies Immunocore ARS Pharmaceuticals Edgewise Therapeutics Schrodinger Biohaven Tarsus Pharmaceuticals (NASDAQ:TARS) and Siga Technologies (NASDAQ:SIGA) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their earnings, risk, profitability, dividends, valuation, media sentiment, analyst recommendations and institutional ownership. Which has preferable valuation & earnings, TARS or SIGA? Siga Technologies has lower revenue, but higher earnings than Tarsus Pharmaceuticals. Tarsus Pharmaceuticals is trading at a lower price-to-earnings ratio than Siga Technologies, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioTarsus Pharmaceuticals$182.95M9.43-$115.55M-$2.73-15.05Siga Technologies$138.72M3.47$59.21M$0.6710.05 Is TARS or SIGA more profitable? Siga Technologies has a net margin of 40.30% compared to Tarsus Pharmaceuticals' net margin of -44.91%. Siga Technologies' return on equity of 25.21% beat Tarsus Pharmaceuticals' return on equity.Company Net Margins Return on Equity Return on Assets Tarsus Pharmaceuticals-44.91% -39.72% -25.74% Siga Technologies 40.30%25.21%22.05% Do institutionals and insiders hold more shares of TARS or SIGA? 90.0% of Tarsus Pharmaceuticals shares are owned by institutional investors. Comparatively, 55.4% of Siga Technologies shares are owned by institutional investors. 9.0% of Tarsus Pharmaceuticals shares are owned by company insiders. Comparatively, 2.0% of Siga Technologies shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth. Does the media favor TARS or SIGA? In the previous week, Tarsus Pharmaceuticals had 2 more articles in the media than Siga Technologies. MarketBeat recorded 2 mentions for Tarsus Pharmaceuticals and 0 mentions for Siga Technologies. Tarsus Pharmaceuticals' average media sentiment score of 1.23 beat Siga Technologies' score of 1.00 indicating that Tarsus Pharmaceuticals is being referred to more favorably in the media. Company Overall Sentiment Tarsus Pharmaceuticals Positive Siga Technologies Positive Which has more volatility & risk, TARS or SIGA? Tarsus Pharmaceuticals has a beta of 0.8, indicating that its stock price is 20% less volatile than the S&P 500. Comparatively, Siga Technologies has a beta of 0.94, indicating that its stock price is 6% less volatile than the S&P 500. Do analysts rate TARS or SIGA? Tarsus Pharmaceuticals currently has a consensus target price of $66.67, suggesting a potential upside of 62.28%. Given Tarsus Pharmaceuticals' stronger consensus rating and higher possible upside, equities research analysts plainly believe Tarsus Pharmaceuticals is more favorable than Siga Technologies.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Tarsus Pharmaceuticals 0 Sell rating(s) 1 Hold rating(s) 5 Buy rating(s) 1 Strong Buy rating(s) 3.00Siga Technologies 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 SummaryTarsus Pharmaceuticals beats Siga Technologies on 10 of the 17 factors compared between the two stocks. Get Siga Technologies News Delivered to You Automatically Sign up to receive the latest news and ratings for SIGA and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding SIGA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart SIGA vs. The Competition Export to ExcelMetricSiga TechnologiesMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$481.15M$2.41B$5.49B$9.02BDividend YieldN/A1.77%5.38%4.09%P/E Ratio10.058.9827.4720.28Price / Sales3.47669.85408.30121.41Price / Cash7.98157.0736.6357.47Price / Book2.234.638.095.67Net Income$59.21M$31.34M$3.17B$248.96M7 Day Performance4.26%3.25%2.82%3.30%1 Month Performance9.51%6.80%3.69%5.20%1 Year Performance-12.98%1.89%35.42%21.37% Siga Technologies Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)SIGASiga Technologies1.6095 of 5 stars$6.74+0.8%N/A-13.0%$481.15M$138.72M10.0540TARSTarsus Pharmaceuticals2.2582 of 5 stars$40.60-0.1%$66.67+64.2%+42.0%$1.71B$182.95M-14.8750Positive NewsBEAMBeam Therapeutics2.7495 of 5 stars$16.71-0.3%$48.75+191.7%-14.7%$1.69B$63.52M-3.62510CNTACentessa Pharmaceuticals3.2376 of 5 stars$13.00+4.6%$27.89+114.5%+67.1%$1.66B$6.85M-7.18200ARQTArcutis Biotherapeutics2.0914 of 5 stars$14.40+4.2%$18.80+30.6%+42.9%$1.65B$196.54M-13.85150Positive NewsADPTAdaptive Biotechnologies3.4667 of 5 stars$10.56+1.7%$10.57+0.1%+253.3%$1.58B$178.96M-11.00790Gap UpIMCRImmunocore2.3853 of 5 stars$31.12-0.7%$58.89+89.2%-8.4%$1.57B$310.20M-72.37320SPRYARS Pharmaceuticals3.1316 of 5 stars$16.57+4.9%$31.00+87.1%+81.4%$1.55B$89.15M-103.5690Positive NewsInsider TradeEWTXEdgewise Therapeutics2.5086 of 5 stars$14.18-0.8%$39.78+180.5%-29.1%$1.50BN/A-9.1560News CoverageAnalyst RevisionSDGRSchrodinger2.8702 of 5 stars$20.35-0.5%$32.80+61.2%+4.3%$1.50B$207.54M-7.74790Analyst ForecastBHVNBiohaven3.4335 of 5 stars$14.44-0.2%$58.46+305.0%-56.7%$1.48BN/A-1.54239 Related Companies and Tools Related Companies Tarsus Pharmaceuticals Alternatives Beam Therapeutics Alternatives Centessa Pharmaceuticals Alternatives Arcutis Biotherapeutics Alternatives Adaptive Biotechnologies Alternatives Immunocore Alternatives ARS Pharmaceuticals Alternatives Edgewise Therapeutics Alternatives Schrodinger Alternatives Biohaven Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:SIGA) was last updated on 7/4/2025 by MarketBeat.com Staff From Our Partners[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | Sponsored379 passengers walked away from thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredHave you heard of “E.I.”?Inside Expert: New "E.I." Tech Could Be Poised For 200,000% Growth Meta, Apple, and even NASA are rushing t...Behind the Markets | SponsoredPost-Halving = Profit Season (Here’s How to Win It)It happens like clockwork. Every four years, the crypto market enters a new phase — and for those who know how...Crypto Swap Profits | SponsoredGold: Now legal tender in many statesThe perfect gold play right now? (currently under $10) Everything in the news now lines up perfectly for an...Stansberry Research | SponsoredGold is soaring. Here’s how to get paid from itGold just broke through $3,300… And while the headlines shout about price targets, something even more powe...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Siga Technologies Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Siga Technologies With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free SIGA Stock Alerts